Stalevo ® 100/25/200 mg 100/25/200 mg (combination) Tablet Emirati Għarab Maqgħuda - Ingliż - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

stalevo ® 100/25/200 mg 100/25/200 mg (combination) tablet

city medical store - sole proprietorship l.l.c finland - 100's bottle - tablet - 100/25/200 mg (combination) - central nervous system-parkinsonism , related disorders

DBL GLYCERYL TRINITRATE 50mg/10mL Injection Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

dbl glyceryl trinitrate 50mg/10ml injection

pfizer australia pty ltd - glyceryl trinitrate, quantity: 50 mg - injection, concentrated - excipient ingredients: ethanol absolute; propylene glycol; water for injections - glyceryl trinitrate concentrate injection is indicated for: control of blood pressure in perioperative hypertension associated with surgical procedures, especially cardiovascular procedures, such as the hypertension seen during intratracheal intubation, anaesthesia, skin incision, sternotomy, cardiac bypass and in the immediate post-surgical period. congestive heart failure associated with acute myocardial infarction. treatment of angina pectoris in patients who have not responded to recommended doses of organic nitrates and/or a beta blocker. production of controlled hypotension during neurosurgical and orthopaedic surgical procedures.

Glyceryl Trinitrate 5 mg/ml Sterile Concentrate Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

glyceryl trinitrate 5 mg/ml sterile concentrate

pfizer healthcare ireland - glyceryl trinitrate - concentrate for solution for infusion - 5 milligram(s)/millilitre - organic nitrates; glyceryl trinitrate

Retrovir 100 mg/10 ml oral solution Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

retrovir 100 mg/10 ml oral solution

viiv healthcare bv - zidovudine - oral solution - 100 milligram/ 10 millilitre - nucleoside and nucleotide reverse transcriptase inhibitors; zidovudine

XYLONOR PELLETS solution bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

xylonor pellets solution bottle

specialites septodont pty ltd - lidocaine, quantity: 50 mg/ml; cetrimide, quantity: 1.5 mg/ml - solution - excipient ingredients: saccharin; propylene glycol; purified water; glycerol; spearmint oil - topical anaesthesia and disinfection of the mucosa before;,- injections,- extraction of mobile, deciduous or permanent teeth,- extraction of teeth due to pyorrhoea,- adjusting and fitting of crowns & bridges,- lancing of abscesses,- scaling

IDEDEX READY TO USE TEAT DIP & SPRAY WITH EMOLLIENT Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

idedex ready to use teat dip & spray with emollient

nutrien ag solutions limited - iodine; glycerol - topical solution/suspension - iodine mineral-iodine active 5.0 g/l; glycerol solvent active 50.0 g/l - dermatological preps. - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - teat sanitiser

Lidocaine-Baxter New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

lidocaine-baxter

baxter healthcare ltd - lidocaine hydrochloride monohydrate 10.66 mg/ml equivalent to lidocaine hydrochloride 10.0 mg/ml - solution for injection - 1% w/v - active: lidocaine hydrochloride monohydrate 10.66 mg/ml equivalent to lidocaine hydrochloride 10.0 mg/ml excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - lidocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: local infiltration; minor or major nerve blocks; epidural block; arthroscopy; intravenous regional anaesthesia.

Nitroderm TTS 10 New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

nitroderm tts 10

sandoz new zealand limited - glyceryl trinitrate 50mg (releasing 10mg/24h) - transdermal patch - 10 mg/24h - active: glyceryl trinitrate 50mg (releasing 10mg/24h) - treatment of angina pectoris as monotherapy or in combination with other anti-anginal drugs such as beta-blockers and/or calcium antagonists.